Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Bryn Launer, MD

Advertisement

Launer is a urology resident at Vanderbilt University Medical Center, Nashville, Tennessee.

Articles by Bryn Launer, MD

Gorodenkoff - stock.adobe.com

Considerations for palliative care in urologic oncology

ByBryn Launer, MD,Kristen R. Scarpato, MD, MPH
November 25th 2021

Benefits include improved quality of life and symptom management.

Advertisement

Latest Updated Articles

  • Gorodenkoff - stock.adobe.com
    Considerations for palliative care in urologic oncology

    Published: November 25th 2021 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance

2

Taylor Goodstein, MD, highlights contemporary experience with gene therapies for NMIBC

3

Jim Hu, MD, discusses new posterior approach to nerve-sparing prostatectomy

4

Permanent J code for mitomycin for intravesical solution now in effect

5

The Expert APProach: Digital Health, AI, and the Evolving Role of APPs in Urology, with Jennifer Bepple, MD, MMCi

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us